brusatol has been researched along with Injury, Myocardial Reperfusion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PS; Chen, YG; Cheng, Y; Hao, PP; Hu, B; Jiang, TY; Li, XT; Liu, WC; Tian, T; Xue, FS | 1 |
1 other study(ies) available for brusatol and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats.
Topics: Animals; Apoptosis; Dexmedetomidine; Male; Myocardial Reperfusion Injury; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; Sirtuin 3; Superoxide Dismutase | 2023 |